Showing results (161-170 of 298) with videos related to
Sort By:
Pageof 30
European Journal of Gastroenterology & Hepatology|June 9, 2007
Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypesAkihiko Oguri, Naoki Ohmiya, Ayumu Taguchi, et al.Toxicology and Applied Pharmacology|August 25, 2006
Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivationKazuhiro Ishiguro, Takafumi Ando, Osamu Maeda, et al.Oncology Reports|June 21, 2006
Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer cellsOsamu Maeda, Masashi Kondo, Takayoshi Fujita, et al.Cancer Science|September 24, 2010
Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancerTomoya Shimokata, Yuichi Ando, Yoshinari Yasuda, et al.International Cancer Conference Journal|October 3, 2022
A rapid and durable response to larotrectinib in a patient with NTRK fusion-positive secretory carcinoma originating from the external auditory canalYuichi Ando, Sachi Morita, Tomoya Shimokata, et al.Cancer Chemotherapy and Pharmacology|April 28, 2005
Sequence effect of docetaxel and carboplatin on toxicity, tumor response and pharmacokinetics in non-small-cell lung cancer patients: a phase I study of two sequencesMaki Ando, Hideo Saka, Yuichi Ando, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 28, 2025
Clinical characteristics of immune checkpoint inhibitor-related pancreatic injury with pancreatitis in patients with advanced malignanciesTakaya Suzuki, Kazuyuki Mizuno, Takafumi Yamamoto, et al.Molecular and Clinical Oncology|December 1, 2016
Muscle wasting associated with the long-term use of mTOR inhibitorsBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.Investigational New Drugs|December 6, 2011
First clinical pharmacokinetic dose-escalation study of sagopilone, a novel, fully synthetic epothilone, in Japanese patients with refractory solid tumorsKazuhiro Araki, Koichi Kitagawa, Hirofumi Mukai, et al.Cancer Science|August 21, 2020
Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trialYoshihiro Nishida, Shunsuke Hamada, Hiroshi Urakawa, et al.Pageof 30